<div id="readability-page-1"><p>Ambiq Micro, Inc. ((AMBQ)) has held its Q1 earnings call. Read on for the main highlights of the call.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>Ambiq Micro, Inc. struck an upbeat tone on its latest earnings call, pointing to rapid revenue growth, expanding design wins, and a solid balance sheet as proof that its Edge AI strategy is gaining traction. Management acknowledged persistent losses and cost pressures, but argued that accelerating demand and greater customer diversification give the company strong momentum into the next several quarters.</p> <h2>Strong Revenue Growth</h2> <p>Ambiq delivered Q1 net sales of $25.1 million, a 59.3% year-over-year jump driven by broad-based demand for its ultra‑low‑power Edge AI solutions. Management emphasized that new production ramps at key customers, alongside existing programs, are fueling this top-line acceleration and setting a higher base for future quarters.</p> <h2>Gross Profit and Margin Performance</h2> <p>Non‑GAAP gross profit climbed 56.2% year-over-year to $11.6 million, reflecting the strong revenue growth. Reported non‑GAAP gross margin was 46.2%, down 90 basis points, but excluding a one-time Q1 2025 credit, margins actually improved by about 210 basis points, underscoring underlying pricing and mix benefits.</p> <h2>Confident Near-Term Outlook</h2> <p>For Q2, Ambiq expects net sales of $31 million to $32 million, implying roughly 75% year-over-year growth and a healthy sequential step-up. The company guided non‑GAAP gross margin to 45%–46% and signaled continued momentum into the second half of 2026, suggesting sustained demand rather than a one-off spike.</p> <h2>Diversifying Customer Base</h2> <p>Customer concentration is easing as Ambiq adds new wins and ramps. The top three customers represented about 71% of Q1 2026 sales, down from 86% a year earlier, and management highlighted a new major customer that moved into production during the quarter as a sign of broadening demand.</p> <h2>Growing End-Market Diversification</h2> <p>The business is gradually expanding beyond its traditional wearables stronghold into other low‑power AI markets. Non‑wearable revenue doubled in Q1 and now accounts for roughly a quarter of the pipeline, with management expecting medical, industrial, and smart home or building segments to more than double revenue in 2026.</p> <h2>Product Roadmap Progress and Design Wins</h2> <p>Ambiq’s product roadmap remains busy, with the Apollo 5 family scaling in production and helping lift average selling prices. Further out, Apollo 340 is in design with samples targeted in the first half of 2027, while Atomic 110 and 120 are advancing for late‑decade ramps, and new design wins include a next‑generation product line slated to enter production in 2027.</p> <h2>Strong Balance Sheet</h2> <p>The company closed Q1 with $204.5 million in cash and cash equivalents and no debt, providing ample liquidity for its aggressive investment plans. Management noted that this financial cushion supports ongoing spending on new products, software capabilities, and go‑to‑market efforts without the immediate need for external financing.</p> <h2>Software and System-Level Differentiation</h2> <p>Beyond silicon, Ambiq is leaning into software and system-level value, including a new Compression Kit offering that is initially tied to its own chips. This tool is designed to stretch battery life to multiple days while storing large volumes of raw data and enabling on‑device anomaly detection, reinforcing its pitch for always‑on, ultra‑low‑power AI at the edge.</p> <h2>Ongoing Non-GAAP Net Loss</h2> <p>Despite strong growth, Ambiq remains unprofitable on a non‑GAAP basis, posting a Q1 net loss of $5.0 million, or $0.25 per share. Management guided Q2 non‑GAAP loss per share to between $0.29 and $0.23, signaling that higher operating costs and investments will keep the bottom line in the red near term.</p> <h2>Rising Operating Expenses</h2> <p>Investment is ramping quickly, with non‑GAAP R&amp;D spending up 43.3% year-over-year to $10.1 million and SG&amp;A up 31.8% to $8.1 million in Q1. For 2026, Ambiq expects around $85 million in operating expenses including sizable intellectual property purchases, underlining its decision to prioritize growth and product depth over short-term profitability.</p> <h2>Margin Headwinds from Industry Costs</h2> <p>While yields are improving, broader industry cost inflation is limiting margin expansion, particularly in substrates and other components. Management expects gross margins to remain roughly flat year-over-year, meaning earnings leverage will depend more on revenue scale than on near‑term efficiency gains.</p> <h2>Supply and Lead-Time Constraints</h2> <p>Demand is robust enough that Ambiq is occasionally unable to satisfy customers’ very short lead‑time orders, even with strong manufacturing partners. The company noted a rise in expedited requests and some unmet demand during sudden surges, a growing‑pains dynamic that could both cap upside and underscore the urgency to expand capacity.</p> <h2>Path to Profitability and Scale</h2> <p>Management estimates that, at current margin and expense levels, Ambiq needs roughly $47 million of quarterly revenue to reach non‑GAAP breakeven, nearly double Q1’s run‑rate. This framing highlights both the scale of the opportunity and the execution challenge in growing fast enough to cover elevated operating costs while maintaining competitive technology leadership.</p> <h2>Customer Concentration and Timing Risk</h2> <p>Even with improving diversification, a small group of large customers still accounts for the majority of revenue, leaving Ambiq exposed to launch schedules and order timing. The company cautioned that as multiple customers ramp new products, quarter‑to‑quarter results could be lumpy, introducing volatility even against a strong underlying growth curve.</p> <h2>Forward-Looking Guidance and Targets</h2> <p>Guidance calls for a strong Q1 to Q2 cadence, with sales climbing from $25.1 million to $31–32 million and gross margins holding in the mid‑40% range despite cost pressures. For 2026, Ambiq expects revenue growth in the second half to mirror the first, operating expenses around $85 million, largely stable gross margins, and a breakeven revenue level near $47 million per quarter, with profitability targeted between late 2027 and mid‑2028.</p> <p>Ambiq Micro’s latest earnings call painted the picture of a fast‑growing chip and software specialist trading near‑term losses for long‑term scale in Edge AI. Investors will have to weigh the strong revenue trajectory, rich pipeline, and cash buffer against margin headwinds, rising costs, and concentration risk as the company races toward the breakeven threshold it has now clearly defined.</p></div>

AMBQ

SOXX

SOXL

FTXL

<p>Ambiq Micro, Inc. reported strong Q1 earnings with a 59.3% year-over-year revenue growth, reaching $25.1 million, driven by demand for its Edge AI solutions. Despite ongoing losses, management is optimistic about future growth, projecting Q2 sales of $31-32 million. The company is diversifying its customer base and expanding into new markets, with a solid balance sheet of $204.5 million in cash. However, rising operating expenses and industry cost inflation pose challenges to profitability, with a Q1 net loss of $5 million. Ambiq aims for breakeven at $47 million in quarterly revenue.</p>

Ambiq Micro Earnings Call Signals Fast-Growth Phase